HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Cordon-Cardo Selected Research

Tics (Tic)

1/2019Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts.
1/2017Targeting sarcoma tumor-initiating cells through differentiation therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Cordon-Cardo Research Topics

Disease

136Neoplasms (Cancer)
02/2024 - 01/2002
54Prostatic Neoplasms (Prostate Cancer)
12/2023 - 05/2002
27Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2002
23Carcinogenesis
11/2022 - 03/2004
22COVID-19
02/2024 - 05/2020
19Neoplasm Metastasis (Metastasis)
07/2021 - 04/2002
18Melanoma (Melanoma, Malignant)
06/2014 - 01/2002
11Carcinoma (Carcinomatosis)
12/2019 - 01/2002
9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2015 - 10/2007
8Sarcoma (Soft Tissue Sarcoma)
11/2022 - 09/2002
8Adenocarcinoma
01/2017 - 12/2002
7Disease Progression
01/2022 - 01/2009
7Breast Neoplasms (Breast Cancer)
01/2017 - 02/2004
6Prostatic Intraepithelial Neoplasia
01/2023 - 02/2004
6Colorectal Neoplasms (Colorectal Cancer)
11/2016 - 02/2003
5Lymphoma (Lymphomas)
12/2019 - 02/2004
5Leukemia
10/2015 - 03/2004
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2015 - 01/2009
4Infections
01/2023 - 01/2021
4Inflammation (Inflammations)
05/2022 - 11/2010
4Hypoxia (Hypoxemia)
01/2021 - 08/2006
4Lymphatic Metastasis
05/2010 - 02/2004
3Colonic Neoplasms (Colon Cancer)
11/2016 - 02/2004
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2010 - 10/2003
2Mpox (monkeypox)
12/2023 - 01/2023
2Zoonoses
12/2023 - 01/2023
2Multiple Myeloma
11/2023 - 01/2021
2Chromosomal Instability (Chromosome Stability)
01/2023 - 09/2002
2Liver Neoplasms (Liver Cancer)
07/2021 - 06/2008
2Tics (Tic)
01/2019 - 01/2017
27 Hereditary Prostate Cancer
01/2017 - 08/2015

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2002
23Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2003
15DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2002
12RNA (Ribonucleic Acid)IBA
01/2023 - 02/2003
11Messenger RNA (mRNA)IBA
02/2024 - 03/2002
10AndrogensIBA
12/2023 - 05/2002
10AntibodiesIBA
01/2023 - 08/2004
10MicroRNAs (MicroRNA)IBA
12/2018 - 06/2005
9Transcription Factors (Transcription Factor)IBA
12/2023 - 05/2006
9ParaffinIBA
11/2016 - 01/2002
9TOR Serine-Threonine KinasesIBA
12/2009 - 08/2005
8Androgen Receptors (Androgen Receptor)IBA
07/2018 - 05/2002
7Phosphotransferases (Kinase)IBA
01/2023 - 11/2005
7Interleukin-6 (Interleukin 6)IBA
05/2022 - 06/2015
7Prostate-Specific Antigen (Semenogelase)IBA
10/2011 - 07/2003
6Docetaxel (Taxotere)FDA Link
09/2020 - 03/2005
6Complementary DNA (cDNA)IBA
01/2015 - 12/2002
6Sirolimus (Rapamycin)FDA Link
12/2009 - 03/2004
5CytokinesIBA
05/2022 - 01/2011
5VaccinesIBA
03/2022 - 01/2012
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2017 - 05/2006
5PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2017 - 01/2009
5Monoclonal AntibodiesIBA
11/2016 - 02/2002
5Protein Isoforms (Isoforms)IBA
04/2012 - 02/2002
4AntigensIBA
01/2023 - 01/2012
4CarcinogensIBA
12/2019 - 11/2010
4Hormones (Hormone)IBA
08/2015 - 08/2004
4SmokeIBA
11/2010 - 01/2004
4Eukaryotic Initiation Factor-4EIBA
01/2010 - 03/2004
3Circular RNAIBA
11/2022 - 01/2019
3HLA Antigens (Human Leukocyte Antigens)IBA
10/2021 - 01/2017
3Interleukin-8 (Interleukin 8)IBA
01/2021 - 05/2020
3Indicators and Reagents (Reagents)IBA
01/2019 - 01/2003
3Phenobarbital (Luminal)FDA Link
11/2018 - 03/2011
3PolyaminesIBA
01/2018 - 12/2016
3Mechanistic Target of Rapamycin Complex 1IBA
01/2017 - 08/2008
3TensinsIBA
01/2017 - 01/2009
3taxaneIBA
01/2017 - 03/2005
3ErbB Receptors (EGF Receptor)IBA
11/2016 - 02/2003
3Epidermal Growth Factor (EGF)IBA
11/2016 - 02/2003
3GlucocorticoidsIBA
12/2013 - 01/2009
3OligonucleotidesIBA
02/2006 - 01/2002
3Oncogene Proteins (Oncogene Protein)IBA
08/2005 - 09/2003
3Antisense OligonucleotidesIBA
03/2005 - 03/2002
2VimentinIBA
02/2024 - 09/2004
23- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
12/2023 - 01/2023
2LipidsIBA
01/2023 - 01/2018
2Conditioned Culture MediaIBA
05/2022 - 02/2011
2SynucleinsIBA
01/2022 - 02/2006
2Neutralizing AntibodiesIBA
01/2021 - 12/2020
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 12/2004
2Antiviral Agents (Antivirals)IBA
11/2020 - 07/2020
2ChromatinIBA
01/2019 - 01/2005
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2019 - 07/2010
2AcidsIBA
01/2019 - 05/2003
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2019 - 05/2003
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2017 - 03/2004
2EnzymesIBA
12/2016 - 03/2004
2Formaldehyde (Formol)FDA Link
11/2016 - 04/2016
2Cadherins (E-Cadherin)IBA
08/2015 - 01/2014
2Desmoglein 2IBA
08/2015 - 01/2014

Therapy/Procedure

42Therapeutics
12/2023 - 02/2002
15Drug Therapy (Chemotherapy)
01/2023 - 02/2003
14Prostatectomy (Retropubic Prostatectomy)
05/2022 - 03/2004
6Castration
12/2023 - 05/2002
4Radiotherapy
01/2019 - 05/2003
3Precision Medicine
10/2015 - 07/2009
2Transplantation
12/2019 - 08/2009
2Cystectomy
04/2015 - 10/2006